Key result
Higher adiponectin is linked to ~17% lower odds of vascular reactivity dysfunction in CAD.
Why the study?
Adiponectin has anti-inflammatory and antiatherogenic properties, but its potential correlation with endothelial function in patients with CAD required evaluation.
Is serum adiponectin level associated with vascular reactivity index in patients with coronary artery disease?
Cross-Sectional (n=125)
No
Is serum adiponectin level associated with vascular reactivity index in patients with coronary artery disease?
Odds Ratio: 0.831 (95% CI 0.764–0.905)
p-value: p=<0.001
Higher fasting serum adiponectin levels are independently associated with better endothelial function, as measured by the vascular reactivity index, in patients with coronary artery disease.
Supports hypothesis linking adiponectin to endothelial function in CAD; leaves open causality and need for prospective trials.
Objectives: Adiponectin has anti-inflammatory and antiatherogenic effects and is important in the pathogenesis of cardiovascular diseases. In this cross-sectional study, our objective was to study the potential correlation between serum adiponectin levels and endothelial function in participants with coronary artery disease (CAD). Materials and Methods: We collected serum specimens from 125 fasting participants with CAD. The endothelial function was measured using the vascular reactivity index (VRI) determined by digital thermal monitoring, and VRI values of >2.0, 1.0-1.9, and <1.0 indicated good, intermediate, and poor vascular reactivity, respectively. A commercially available enzyme immunoassay kit was used to measure serum adiponectin levels. Results: The cohort included 55, 57, and 13 patients with good, intermediate, and poor vascular reactivity, respectively. Poor vascular reactivity was shown to be associated with older age, higher levels of serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), C-reactive protein, and lower levels of serum albumin and adiponectin. The linear regression analysis with multivariable forward stepwise approach revealed that age (β = -0.232), serum LDL-C (β = -0.264), and serum adiponectin (β = 0.574) were correlated with the VRI in CAD patients significantly. Conclusion: Fasting serum adiponectin levels were associated with good endothelial function determined using the VRI in patients with CAD.
No takes yet. Share an insight, caveat, or question.
Hsiao et al. (2023) conducted a cross-sectional in Coronary artery disease (n=125). Serum adiponectin level was evaluated on Vascular reactivity dysfunction (intermediate or poor vascular reactivity index) (OR 0.831, 95% CI 0.764-0.905, p=<0.001). Higher serum adiponectin levels were independently associated with a lower risk of vascular reactivity dysfunction in patients with coronary artery disease (OR 0.831).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: